Select Biotechs See Early Action on GILD/VRUS Deal
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Join SI Premium – FREE
A certain number of biotech stocks are seeing action in pre-open action Monday following Gilead Sciences (Nasdaq: GILD) deal to acquire Pharmasset (Nasdaq: VRUS) at a 89% premium.
Movers:
Inhibitex, Inc. (Nasdaq: INHX) +31%
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) +3%
Idenix Pharmaceuticals Inc. (Nasdaq: IDIX) - indicated higher.
Movers:
Inhibitex, Inc. (Nasdaq: INHX) +31%
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) +3%
Idenix Pharmaceuticals Inc. (Nasdaq: IDIX) - indicated higher.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVIDIA (NVDA) in talks to invest in data-center company Cloverleaf Infrastructure - WSJ
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- Buyout firm Vista explores $3B sale of private markets data provider Allvue - Reuters
Create E-mail Alert Related Categories
Rumors, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
